financetom
Business
financetom
/
Business
/
Tata Power completes sale of its defence biz to Tata Advanced Systems
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata Power completes sale of its defence biz to Tata Advanced Systems
Nov 2, 2020 4:39 AM

Tata Power on Monday said it has completed the sale of its defence business to Tata Advanced Systems. Tata Advanced Systems is a wholly-owned subsidiary of Tata Sons. ”The sale was completed as per a Scheme of Arrangement, which was approved by the National Company Law Tribunal at Mumbai and Hyderabad in December 2019 and March 2020, respectively,” Tata Power said in a regulatory filing. The company said it is expected to receive an enterprise value of Rs 1,076 crore as an upfront payment.

Balance consideration is subject to completion of achieving certain milestones specified in the agreements, the company added. Tata Power said the sale of defence business is part of the company’s ongoing strategic plan to monetise its non-core assets and reduce overall leverage.

”The sale proceeds will help the company to reduce leverage and increase focus in the core business areas like renewable generation, distribution and new service-led businesses which will bring greater value for our shareholders,” Praveer Sinha, CEO and Managing Director, Tata Power said. Strategic Engineering Division (SED) is a non-core defence electronics division of the company, engaged in business of indigenous design, development, production, integration, supply and life cycle support of mission-critical defence systems.

The key products include manufacturing and assembling missile launchers, electronic warfare, night vision systems and gun systems. SED has three dedicated manufacturing units — Bangalore Electronic City, Vemagal in Karnataka (under construction) and an SEZ near Bengaluru (under construction).

First Published:Nov 2, 2020 1:39 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trump raises concerns about US ban on TikTok
Trump raises concerns about US ban on TikTok
Mar 8, 2024
WASHINGTON, March 8 (Reuters) - Presidential candidate Donald Trump raised concerns about banning TikTok ahead of a vote next week by the U.S. House of Representatives that would give TikTok owner ByteDance about six months to divest the popular short video app. The former Republican president seeking a return to the White House wrote late Thursday on social media site...
National Bank Of Canada Comments On Kelt Exploration's Q4 2023 Results
National Bank Of Canada Comments On Kelt Exploration's Q4 2023 Results
Mar 8, 2024
11:01 AM EST, 03/08/2024 (MT Newswires) -- National Bank of Canada said Friday that Kelt Exploration Ltd. ( KELTF ) 's cash flow per share of $0.33 beat the consensus forecast of $0.32. Average production of 32,300 barrels of oil equivalent per day matched the bank's forecast. National Bank said Kelt delivered a solid culmination to the year while the...
DoorDash Canada Introduces Platform Supporting Women-Owned Restaurants
DoorDash Canada Introduces Platform Supporting Women-Owned Restaurants
Mar 8, 2024
11:03 AM EST, 03/08/2024 (MT Newswires) -- DoorDash ( DASH ) Canada introduced Made by Women, a new platform that supports women chefs and restaurateurs. The company said it partnered with Monday Girl to provide fifteen CA$10,000 ($7,428) grants to women-owned restaurants in Canada. Price: 133.08, Change: -0.12, Percent Change: -0.09 ...
Eli Lilly Alzheimer's Disease Candidate Donanemab Delayed as FDA Convenes Surprise Meeting
Eli Lilly Alzheimer's Disease Candidate Donanemab Delayed as FDA Convenes Surprise Meeting
Mar 8, 2024
11:01 AM EST, 03/08/2024 (MT Newswires) -- Eli Lilly and Co. ( LLY ) said Friday that its Alzheimer's Disease drug candidate donanemab will be delayed beyond the first quarter as the US Food and Drug Administration convenes a surprise meeting to gather more information about a late-stage trial. The regulatory body is expected to convene a meeting with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved